In the four months following the COVID-19 pandemic’s arrival in the U.S., the number of patients initiating treatment for kidney failure declined by 30%, a new study in JAMA Network Open found. Notably, Black patients and patients living in counties with high numbers of COVID-19 deaths initiated treatment with significantly worse levels of kidney function when compared to prior years.